Sort   by:  
 Page size 
UnknownAdult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.
Not available
S-EPMC5644573 | biostudies-literature
UnknownAdult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
Not available
S-EPMC5931085 | biostudies-literature
UnknownFine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Not available
S-EPMC5995836 | biostudies-literature
UnknownGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.
Not available
S-EPMC5010513 | biostudies-literature
UnknownGermline variation at 8q24 and prostate cancer risk in men of European ancestry.
Not available
S-EPMC6218483 | biostudies-literature
UnknownPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Not available
S-EPMC5200636 | biostudies-literature
UnknownGWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Not available
S-EPMC10208981 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
UnknownAspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213 | biostudies-literature
Sort   by:  
 Page size